Patents by Inventor John G. Devane

John G. Devane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6902742
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: June 7, 2005
    Assignee: Elan Corporation, plc
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning, Gurvinder Singh Rekhi
  • Publication number: 20040197405
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Application
    Filed: April 19, 2004
    Publication date: October 7, 2004
    Applicant: Elan Corporation, plc
    Inventors: John G. Devane, Paul Stark, Niall M.M. Fanning, Gurvinder Singh Rekhi
  • Patent number: 6793936
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: September 21, 2004
    Assignee: Elan Corporation, plc
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning
  • Patent number: 6730325
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: May 4, 2004
    Assignee: Elan Corporation, plc
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning
  • Publication number: 20030170304
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Application
    Filed: January 30, 2003
    Publication date: September 11, 2003
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning
  • Publication number: 20030129237
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component compnsimg a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Application
    Filed: December 30, 2002
    Publication date: July 10, 2003
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning, Gurvinder Singh Rekhi
  • Publication number: 20020054907
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component comprising a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Application
    Filed: May 7, 2001
    Publication date: May 9, 2002
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning
  • Patent number: 6228398
    Abstract: The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component compnsimg a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: May 8, 2001
    Assignee: Elan Corporation, PLC
    Inventors: John G. Devane, Paul Stark, Niall M. M. Fanning